Inari Medical (NARI) | Stock Overview & Key Data
Inari Medical Performance Comparison
Stock Range
Today's Range
Low: $79.97
High: $79.97
on June 20, 2025
52 Week Range
Low: $36.73
High: $79.99
on April 22, 2024
on February 18, 2025
All-Time High: $79.97 on February 19, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$4.7B
EPS
-1.35
P/E Ratio (TTM)
-2,665.67
Forward P/E
571.21
P/B Ratio
10.75
PEG Ratio
571.21
Div. Yield
N/A
ROE
-17.72%
Beta
1.028
Debt to Equity
7.53
Financial Highlights
Profitability
Gross Margin
87.06%
Operating Margin
-4.34%
Profit Margin
-13.68%
Returns and Earnings
Return on Assets (TTM)
-3.21%
Return on Equity (TTM)
-17.72%
EBITDA
$15.2M
Net Income (TTM)
$-78.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.95
Quarterly Revenue Growth (YoY)
21.40%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Inari Medical NARI | 4.68B Mid-cap | 0.06% | 0.59% | 56.90% | 76.22% | 54.38% | N/A | N/A | N/A |
| Abbott Laboratories ABT | 229.31B Mega-cap | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% | 17.14% | 29.54% | 19.14% |
| Boston Scientific BSX | 153.73B Large-cap | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% | 32.89% | 159.65% | 156.42% |
| Masimo MASI | 7.97B Mid-cap | -5.02% | -7.02% | -3.45% | -15.13% | -14.43% | 20.26% | -4.97% | -34.37% |
| Globus Medical GMED | 8.26B Mid-cap | 0.80% | 16.59% | 2.06% | -24.64% | -26.07% | -16.03% | 0.27% | 7.14% |
| Bio-Rad BIO.B | 7.27B Mid-cap | 0.00% | -4.15% | -1.21% | -20.83% | -24.12% | -11.52% | -44.29% | -44.36% |
Ownership & Short Interest
Insider Ownership
9.00%
Institutional Ownership
95.56%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1M
Average 90-Day Volume
3M
Inari Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Inari Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NARI's 52-week high and low?
- In the last 52 weeks, Inari Medical reached a high of $79.99 (on February 18, 2025) and a low of $36.73 (on April 22, 2024).
- What is the market cap and P/E ratio for NARI?
- Curious about Inari Medical's size and valuation? Its market capitalization stands at 4.68B. When it comes to valuation, the P/E ratio (trailing twelve months) is -2,665.67, and the forward P/E (looking ahead) is 571.21.
- Does NARI pay dividends? If so, what's the yield?
- As for dividends, Inari Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Inari Medical's main competitors or similar companies to consider before investing?
When looking at Inari Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT229.31B Healthcare Medical Devices 17.14% 29.54% Boston Scientific
BSX153.73B Healthcare Medical Devices 32.89% 159.65% Masimo
MASI7.97B Healthcare Medical Devices 20.26% -4.97% Globus Medical
GMED8.26B Healthcare Medical Devices -16.03% 0.27% Bio-Rad
BIO.B7.27B Healthcare Medical Devices -11.52% -44.29% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Inari Medical Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Inari Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -17.72%, the Debt to Equity ratio from the most recent quarter is 7.53, and its Gross Profit Margin stands at 87.06%.
- What is the recent revenue and earnings growth for NARI?
- Looking at Inari Medical's growth, its revenue over the trailing twelve months (TTM) was $574M. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.40%, and quarterly earnings saw a YoY growth of N/A.
- How much of NARI stock is held by insiders and institutions?
- Wondering who owns Inari Medical stock? Company insiders (like executives and directors) hold about 9.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.56%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.